Catapult Genetics

About:

Catapult Genetics develops and commercializes livestock DNA tests and gene markers for food producers, processors, and retailers.

Website: http://www.geneticsolutions.com.au

Top Investors: Kestrel Capital, Nanyang Ventures

Description:

Catapult Genetics Pty., Ltd. develops and commercializes livestock DNA tests and gene markers for food producers, processors, and retailers in the livestock and aquaculture industries. Its products include GeneSTAR feed efficiency4, a test for four separate DNA markers that affects feed efficiency in an animal; GeneSTAR marbling4, a test for four separate DNA markers that affects marbling in an animal; GeneSTAR tenderness4, a test for four separate DNA markers that affects tenderness in the carcase; and SireTRACE, which uses DNA profiling to identify parentage in multiple sire mating situations. The company's products also include SureTRAK, a DNA verification system for traceability of carcase, primal cut, or meat products to source animal; GH Exon 5, which represents a method for evaluating wagyu cattle for the characteristics of growth rate and marbling; SCD, which is designed to assist in the selection of cattle that shows a genotype; and DNA Tag, a unit that combines a NLIS tag, visual management tag, and DNA sample collector. It serves stud and commercial breeders, pastoral companies and farming operations, and food processors and biotechnology companies through distribution partners in the United Kingdom, North and South America, Europe, and South Africa. The company has operations in Australia and New Zealand. Catapult Genetics Pty., Ltd. was formerly known as Genetic Solutions Pty Ltd. The company was founded in 1998 and is based in Albion, Australia. As of March 31, 2008, Catapult Genetics Pty., Ltd. operates as a subsidiary of Pfizer Animal Health.

Total Funding Amount:

2.5M AUD

Headquarters Location:

Albion Park, New South Wales, Australia

Founded Date:

1998-01-01

Founders:

Gerard P. Davis, Jay Hetzel

Number of Employees:

11-50

Last Funding Date:

2005-03-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai